Portrait Jonas

Jonas Sommer

Jonas studies Biotechnology at the Berliner Hochschule für Technik and began his bachelor thesis at the AG Lipstein in 2022. He now continues his work on the mechanisms by which human variations in the essential synaptic protein UNC13A lead to neurodevelopmental disease.

Molecular Physiology & Cell Biology

Lipstein Group